Biomatter Raises $18M Series A Funding

Biomatter, a Vilnius-based custom enzyme design provider, raised $18M in Series A funding led by Astanor. The company plans to expand its commercial team and U.S. presence while investing in its computational platform. Founded in 2018, the firm has delivered over 50 custom enzymes to 25 enterprise customers across Europe, the United States, and Japan.